Yale University Patent Portfolio Statistics

tip_user1

Yale University

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Yale University look like?

Total Applications:	1,538
Granted Patents:	830
Grant Index	66.67 %
Abandoned/Rejected Applications:	415 (33.33%)
In-Process Applications:	291
Average Grant Time:	3.36 Years
Average Office Actions:	2.06

Which Technology Area Yale University is filing most patents in? (Last 10 years)

Art Unit	Definition	Total Applications
1635	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	56
Opap	Parked GAU	54
1634	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	53
1636	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	47
1644	Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology	41

How many patents are Yale University filing every year?

Year	Total Applications
2022	0*
2021	37*
2020	72
2019	62
2018	77

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Yale University in USPTO?

Publication number: US20210401955A1
Application number: 17/467,574

Abstract:
The present disclosure relates to compositions and methods for treating or preventing a disease or disorder of immunoprivileged tissue. It is described herein that an immunogenic composition which induces production of memory CD4 T cells allows for the access of a therapeutic antibody to the immunoprivileged tissue.

Publication date: 2021-12-30
Applicant: Yale University
Inventors: Iijima Norifumi

Publication number: US20210401950A1
Application number: 17/407,040

Abstract:
The present invention relates to compositions and methods for modulating coagulation through modulating the level or activity of ENPP4.

Publication date: 2021-12-30
Applicant: Yale University
Inventors: Braddock Demetrios

Publication number: –
Application number: 17/426,762

Abstract:
None

Publication date: –
Applicant: Yale University
Inventors: Chandregowda Venkateshappa

How are Yale University’s applications performing in USPTO?

Application Number	Title	Status	Art Unit	Examiner
17/467,574	Cd4 T Cells Provide Antibody Access To Immunoprivileged Tissue	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17/407,040	Compositions For Treating Pathological Calcification Conditions, And Methods Using Same	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17/426,762	Compounds, Compositions, And Methods For Treating Fibrosis	Sent to Classification contractor	OPAP	Central, Docket
17/425,629	Anticancer Drugs And Methods Of Making And Using Same	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17/423,631	Josephson Nonlinear Circuit	Sent to Classification contractor	OPAP	Central, Docket